269 related articles for article (PubMed ID: 31399066)
21. Chiari malformation Type I surgery in pediatric patients. Part 1: validation of an ICD-9-CM code search algorithm.
Ladner TR; Greenberg JK; Guerrero N; Olsen MA; Shannon CN; Yarbrough CK; Piccirillo JF; Anderson RC; Feldstein NA; Wellons JC; Smyth MD; Park TS; Limbrick DD
J Neurosurg Pediatr; 2016 May; 17(5):519-24. PubMed ID: 26799412
[TBL] [Abstract][Full Text] [Related]
22. Characterization of individuals with selected muscular dystrophies from the expanded pilot of the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) in the United States.
Wallace B; Smith KT; Thomas S; Conway KM; Westfield C; Andrews JG; Weinert RO; Do TQN; Street N;
Birth Defects Res; 2021 Apr; 113(7):560-569. PubMed ID: 32710484
[TBL] [Abstract][Full Text] [Related]
23. Does a claims diagnosis of autism mean a true case?
Burke JP; Jain A; Yang W; Kelly JP; Kaiser M; Becker L; Lawer L; Newschaffer CJ
Autism; 2014 Apr; 18(3):321-30. PubMed ID: 23739541
[TBL] [Abstract][Full Text] [Related]
24. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of validated methods for identifying Bell's palsy using administrative or claims data.
Lee CD; Carnahan RM; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K7-11. PubMed ID: 24331076
[TBL] [Abstract][Full Text] [Related]
26. Validation of an administrative claims coding algorithm for serious opioid overdose: A medical chart review.
Mountcastle SB; Joyce AR; Sasinowski M; Costello N; Doshi S; Zedler BK
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1422-1428. PubMed ID: 31483548
[TBL] [Abstract][Full Text] [Related]
27. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.
Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E;
Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of validated methods to capture acute bronchospasm using administrative or claims data.
Sharifi M; Krishanswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K12-20. PubMed ID: 24331069
[TBL] [Abstract][Full Text] [Related]
29. Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel.
Walsh KE; Cutrona SL; Foy S; Baker MA; Forrow S; Shoaibi A; Pawloski PA; Conroy M; Fine AM; Nigrovic LE; Selvam N; Selvan MS; Cooper WO; Andrade S
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1205-13. PubMed ID: 24038742
[TBL] [Abstract][Full Text] [Related]
30. Using Administrative Data to Ascertain True Cases of Muscular Dystrophy: Rare Disease Surveillance.
Smith MG; Royer J; Mann JR; McDermott S
JMIR Public Health Surveill; 2017 Jan; 3(1):e2. PubMed ID: 28082256
[TBL] [Abstract][Full Text] [Related]
31. Epilepsy in Duchenne and Becker muscular dystrophies.
Goodwin F; Muntoni F; Dubowitz V
Eur J Paediatr Neurol; 1997; 1(4):115-9. PubMed ID: 10728205
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of validated methods for identifying uveitis using administrative or claims data.
Williams SE; Carnahan R; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K88-97. PubMed ID: 24331079
[TBL] [Abstract][Full Text] [Related]
33. Methods for systematic reviews of administrative database studies capturing health outcomes of interest.
McPheeters ML; Sathe NA; Jerome RN; Carnahan RM
Vaccine; 2013 Dec; 31 Suppl 10():K2-6. PubMed ID: 24331070
[TBL] [Abstract][Full Text] [Related]
34. Measurement of the functional status of patients with different types of muscular dystrophy.
Lue YJ; Lin RF; Chen SS; Lu YM
Kaohsiung J Med Sci; 2009 Jun; 25(6):325-33. PubMed ID: 19560997
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of validated methods for identifying Kawasaki disease using administrative or claims data.
Williams CL; Sathe NA; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K28-33. PubMed ID: 24331072
[TBL] [Abstract][Full Text] [Related]
36. Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States.
Whitehead N; Erickson SW; Cai B; McDermott S; Peay H; Howard JF; Ouyang L;
Orphanet J Rare Dis; 2023 Mar; 18(1):65. PubMed ID: 36949506
[TBL] [Abstract][Full Text] [Related]
37. Genitourinary health in a population-based cohort of males with Duchenne and Becker Muscular dystrophies.
Zhu Y; Romitti PA; Caspers Conway KM; Kim S; Zhang Y; Yang M; Mathews KD;
Muscle Nerve; 2015 Jul; 52(1):22-7. PubMed ID: 25297835
[TBL] [Abstract][Full Text] [Related]
38. Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.
Zhu Y; Romitti PA; Conway KM; Andrews J; Liu K; Meaney FJ; Street N; Puzhankara S; Druschel CM; Matthews DJ
Pediatr Neurol; 2014 Jul; 51(1):71-7. PubMed ID: 24785967
[TBL] [Abstract][Full Text] [Related]
39. Duchenne and Becker muscular dystrophy.
Kneppers AL; Ginjaar IB; Bakker E
Methods Mol Med; 2004; 92():311-41. PubMed ID: 14733319
[No Abstract] [Full Text] [Related]
40. [Neuromuscular diseases 2: muscular dystrophies (MD)].
Schara U; Mortier W
Nervenarzt; 2005 Feb; 76(2):219-37; quiz 238-9. PubMed ID: 16092148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
